Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Neurofibromatosis Type I
81%
Ganglioglioma
49%
Pediatrics
45%
Neoplasm
40%
Diseases
31%
Tumor
31%
Magnetic Resonance Imaging
27%
Cochlear Implant
23%
Cochlear Implantation
20%
COVID-19
19%
Hydrocephalus
17%
Apoplexy
17%
Malignant Neoplasm
17%
Subarachnoid Hemorrhage
17%
Genetics
16%
Radiation Therapy
16%
Intracranial Tumor
15%
Clinical Trial
14%
Overall Survival
14%
Chemotherapy
14%
Arnold Chiari Malformation
14%
Recurrent Disease
13%
Neurofibromatosis
13%
Glioblastoma
12%
Malignant Peripheral Nerve Sheath Tumor
12%
Cancer
12%
Plexiform Neurofibroma
12%
Electronic Health Record
12%
Hearing
11%
Brain Ischemia
11%
Sickle-Cell Disease
11%
Breast Cancer
11%
Speech Perception
11%
Biological Marker
10%
Clinical Research
10%
Dural Arteriovenous Fistula
10%
Electrocochleography
10%
Aneurysm
9%
Pediatrics Patient
9%
Central Nervous System
9%
Cardiovascular System
9%
Progression Free Survival
8%
Optic Nerve Glioma
8%
Epileptic Seizure
8%
Neurofibromatosis Type II
8%
Odds Ratio
8%
Brain Infarction
8%
Oligoastrocytoma
8%
Surgeon
8%
Cochlea
8%
Tumor Progression
8%
Circulating Tumor DNA
7%
Pilocytic Astrocytoma
7%
Infection
7%
Carcinogenesis
7%
Prevalence
7%
Hazard Ratio
7%
Syringomyelia
7%
Pathogenesis
7%
Cerebral Hemorrhage
7%
Hearing Impairment
6%
Quality of Life
6%
Connective Tissue Cancer
6%
Surgery
6%
Brain Metastasis
6%
Health Care Cost
6%
Targeted Therapy
6%
Clinical Feature
6%
Ras Signaling
6%
Biopsy Technique
6%
Posterior Fossa
6%
Meningioma
6%
Systematic Review
6%
Cerebrospinal Fluid
6%
Clinician
6%
Histology
6%
Microglia
5%
Morbidity
5%
Patient Referral
5%
Adolescence
5%
Socioeconomic Status
5%
Vestibular Schwannoma
5%
Hemodynamic
5%
Computer Assisted Tomography
5%
Cohort Analysis
5%
Gene Mutation
5%
Retrospective Cohort Study
5%
Vasospasm
5%
Non Small Cell Lung Cancer
5%
Logistic Regression Analysis
5%
Retrospective Study
5%
Oncology
5%
Stereotactic Radiosurgery
5%
Round Window
5%
Cardiovascular Disease
5%
Craniopharyngioma
5%
Central Nervous System Tumor
5%
Neurosurgery
5%
Keyphrases
Neurofibromatosis Type 1 (NF-1)
100%
Neurofibromatosis Type I
65%
Tumor
43%
Autism Spectrum Disorder
24%
Optic Pathway Glioma
23%
Glioblastoma
20%
Autism
20%
Glioma
20%
Cochlear Implant
19%
Astrocytes
19%
Subarachnoid Hemorrhage
19%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
19%
Cochlear Implantation
19%
COVID-19
18%
Neurofibromatosis Type 2
17%
Brain Tumor
15%
Pediatric
15%
Neurofibromin
15%
Clinical Trials
14%
Mouse Model
13%
Hydrocephalus
13%
Overall Survival
13%
95% Confidence Interval
12%
Cardiac Magnetic Resonance Imaging (cMRI)
12%
Meningioma
12%
Merlin
12%
United States
11%
Pilocytic Astrocytoma
10%
Electrocochleography
10%
Clinical Outcomes
10%
Cerebrospinal Fluid
10%
Microglia
10%
Gene Products
10%
Central Nervous System
9%
Aneurysmal Subarachnoid Hemorrhage (aSAH)
9%
Neurofibromatosis
9%
Pediatric Patients
8%
Electronic Health Records
8%
Radiation Therapy
8%
Chemotherapy
8%
Low-grade Glioma
8%
Tumor Suppressor
8%
Progression-free Survival
8%
Delayed Cerebral Ischemia
8%
Photothermal Therapy
8%
Tumor Growth
8%
Tuberous Sclerosis Complex
8%
Alzheimer's Disease
8%
Resection
7%
Dural Arteriovenous Fistula (dAVF)
7%
Alzheime's Disease
7%
Risk Factors
7%
Plexiform Neurofibroma
7%
Odds Ratio
7%
Tumor Cells
7%
Clinical Features
7%
Circulating Tumor DNA (ctDNA)
7%
Tumor Suppressor Gene
6%
Older Adults
6%
National COVID Cohort Collaborative
6%
High Risk
6%
Speech Perception
6%
Cell Growth
6%
Cardiovascular Health
6%
Syringomyelia
6%
Gene Expression
6%
Hazard Ratio
6%
Sarcoma
6%
Research Consortium
6%
Temozolomide
6%
Cochlear Implant Users
6%
Social Responsiveness Scale
6%
Seizure
6%
Central Nervous System Tumors
6%
Hydrocephalus Clinical Research Network
6%
Posthemorrhagic Hydrocephalus
6%
Clinical Research
6%
Gross Total Resection
6%
Chiari Malformation Type I
6%
Neurodevelopmental Disorders
6%
Pediatric Low-grade Glioma
6%
Breast Cancer
6%
Astrocytoma
6%
Hearing Preservation
6%
NF-2
5%
Zebrafish
5%
Phase I Study
5%
White Matter
5%
Schwann Cells
5%
Childhood Autism
5%
Quality of Life
5%
Silent Cerebral Infarction
5%
Tumor Microenvironment
5%
High-grade Glioma
5%
Endoscopic Third Ventriculostomy
5%
Sickle Cell Anemia
5%
Signaling Pathway
5%
Mammalian Target of Rapamycin (mTOR)
5%
Sickle Cell Disease
5%
T Cells
5%